Diva Laboratories (ROCO:4153) EV-to-EBIT : 25.89 (As of Jun. 01, 2024)

Diva Laboratories EV-to-EBIT Chart

Diva Laboratories Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
EV-to-EBIT		Get a 7-Day Free Trial					27.51	23.95	40.79	44.53	29.96

Diva Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															29.96	25.39	20.30	16.22	26.29

Competitive Comparison of Diva Laboratories's EV-to-EBIT

For the Diagnostics & Research subindustry, Diva Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diva Laboratories's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diva Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Diva Laboratories's EV-to-EBIT falls into.

Diva Laboratories EV-to-EBIT Calculation

Diva Laboratories's EV-to-EBIT for today is calculated as:

Diva Laboratories's current Enterprise Value is NT$1,692.0 Mil.
Diva Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$65.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diva Laboratories  (ROCO:4153) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Diva Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Diva Laboratories's Enterprise Value for the quarter that ended in Mar. 2024 was NT$1,718.4 Mil.
Diva Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$65.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diva Laboratories EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Diva Laboratories's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Diva Laboratories (ROCO:4153) Business Description